Clinical Trial Update: Impact of Vascular Endothelial Growth Factor Gene Polymorphisms on Bevacizumab Efficacy in a Sample of Iraqi Patients With Metastatic Colorectal Cancer [Phase 4]

View source ↗

Summary

A Phase 4 study in metastatic colorectal cancer examines how VEGF gene polymorphisms influence bevacizumab efficacy in Iraqi patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Mohammed Mahmood Mohammed | Conditions: Colo-rectal Cancer | Phase 4 | Status: COMPLETED